It was demonstrated that individuals carrying a single MC1R variant exhibit 1.41 higher odds (95% CI: 1.07–1.87) of developing sporadic cutaneous melanoma compared with wildtype homozygous subjects. This evidence concerns the gene MC1R and cutaneous melanoma.